← Open Payments lookup

LARISSA CELLES: Open Payments

NPI 1902178700 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,939 in 80 payments from 32 companies in 2025. Trend: 2023 $1,015 · 2024 $1,571 · 2025 $1,939

Food & beverage: $1,939
CompanyPaymentsAmount
Janssen Biotech, Inc.7$231
E.R. Squibb & Sons, L.L.C.14$207
Celgene Corporation12$147
Incyte Corporation3$84
Karyopharm Therapeutics Inc.3$82
Genentech USA, Inc.3$82
Exelixis Inc.2$80
AstraZeneca Pharmaceuticals LP3$77
EMD Serono, Inc.2$72
BeOne Medicines USA, Inc.2$69

Products named: REBLOZYL, ERLEADA, OPDIVO, OPDUALAG, XPOVIO, CABOMETYX, BRUKINSA, Fabhalta.

Industry payments across CA — which companies pay providers there.